Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1994 2
1995 1
1997 1
1998 1
1999 1
2001 1
2004 2
2007 3
2008 2
2009 1
2010 1
2011 1
2014 1
2015 2
2017 1
2019 3
2020 1
2022 1
2023 0

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
BRCA1: An Endocrine and Metabolic Regulator.
Werner H. Werner H. Front Endocrinol (Lausanne). 2022 Mar 31;13:844575. doi: 10.3389/fendo.2022.844575. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35432218 Free PMC article. Review.
The breast and ovarian cancer susceptibility gene (BRCA1) is a tumor suppressor whose mutation has been associated with the development of breast, ovarian and, probably, other malignancies at young ages. ...Inactivating germline mutations …
The breast and ovarian cancer susceptibility gene (BRCA1) is a tumor suppressor whose mutation has been associat …
Current Approaches to Pancreatic Cancer Screening.
Chhoda A, Lu L, Clerkin BM, Risch H, Farrell JJ. Chhoda A, et al. Am J Pathol. 2019 Jan;189(1):22-35. doi: 10.1016/j.ajpath.2018.09.013. Am J Pathol. 2019. PMID: 30558719 Free article. Review.
Screening for PDAC is not a standard practice among the general population because of its low incidence. However, screening may be beneficial for individuals with familial history, chronic diseases with genetic predispositions, or inherited cancer syndromes, such as …
Screening for PDAC is not a standard practice among the general population because of its low incidence. However, screening may be beneficia …
Hereditary cancer syndromes.
Fostira F, Thodi G, Konstantopoulou I, Sandaltzopoulos R, Yannoukakos D. Fostira F, et al. J BUON. 2007 Sep;12 Suppl 1:S13-22. J BUON. 2007. PMID: 17935271 Review.
The identification of susceptibility genes for specific types of cancer provided the necessary information for the complete characterization of inherited cancer syndromes. ...This review reports the most characteristic hereditary cancer syndromes along …
The identification of susceptibility genes for specific types of cancer provided the necessary information for the complete ch …
Hereditary ovarian carcinoma.
Gallion HH, Smith SA. Gallion HH, et al. Semin Surg Oncol. 1994 Jul-Aug;10(4):249-54. doi: 10.1002/ssu.2980100404. Semin Surg Oncol. 1994. PMID: 8091066 Review.
More recently, genetic predisposition has been recognized as a strong risk factor for ovarian cancer. Three distinct hereditary syndromes have been identified: (1) breast-ovarian cancer syndrome, (2) hereditary nonpolyposis colon cance
More recently, genetic predisposition has been recognized as a strong risk factor for ovarian cancer. Three distinct hereditar …
BRCA2 gene mutation and prostate cancer risk. Comprehensive review and update.
Junejo NN, AlKhateeb SS. Junejo NN, et al. Saudi Med J. 2020 Jan;41(1):9-17. doi: 10.15537/smj.2020.1.24759. Saudi Med J. 2020. PMID: 31915789 Free PMC article. Review.
BRCA1 and BRCA2 mutations have linked with an increased risk for breast, ovarian, and PCa. However, BRCA2 is the most common gene found altered in early-onset of PCa in males younger than 65. BRCA2 mutation has a higher chance of developing an advanced stage of the …
BRCA1 and BRCA2 mutations have linked with an increased risk for breast, ovarian, and PCa. However, BRCA2 is the most common g …
Breast cancer risk and clinical implications for germline PTEN mutation carriers.
Ngeow J, Sesock K, Eng C. Ngeow J, et al. Breast Cancer Res Treat. 2017 Aug;165(1):1-8. doi: 10.1007/s10549-015-3665-z. Epub 2015 Dec 23. Breast Cancer Res Treat. 2017. PMID: 26700035 Review.
With PTEN on several germline gene testing panels, finding PTEN mutations and variants have increased exponentially. PHTS can be differentiated from other hereditary cancer syndromes including Hereditary Breast Ovarian Cancer syndrome, Lynch syndrome, …
With PTEN on several germline gene testing panels, finding PTEN mutations and variants have increased exponentially. PHTS can be differentia …
Hereditary Cancer Syndromes-A Primer on Diagnosis and Management: Part 1: Breast-Ovarian Cancer Syndromes.
Samadder NJ, Giridhar KV, Baffy N, Riegert-Johnson D, Couch FJ. Samadder NJ, et al. Mayo Clin Proc. 2019 Jun;94(6):1084-1098. doi: 10.1016/j.mayocp.2019.02.017. Mayo Clin Proc. 2019. PMID: 31171119 Review.
Hereditary causes occurring due to pathogenic sequence variants and defects in certain genes makes up roughly 5% of all colorectal cancers and breast-ovarian cancers. High-risk hereditary predisposition syndromes have been associated with a substantial …
Hereditary causes occurring due to pathogenic sequence variants and defects in certain genes makes up roughly 5% of all colorectal cancer
Hereditary breast cancer: part I. Diagnosing hereditary breast cancer syndromes.
Lynch HT, Silva E, Snyder C, Lynch JF. Lynch HT, et al. Breast J. 2008 Jan-Feb;14(1):3-13. doi: 10.1111/j.1524-4741.2007.00515.x. Epub 2007 Dec 11. Breast J. 2008. PMID: 18086272 Review.
Hereditary breast cancer (HBC) accounts for as much as 10% of the total BC burden. ...Confounding factors include its phenotypic and genotypic heterogeneity, given the association of HBC with a plethora of differing cancer syndromes. Its most common occurrenc …
Hereditary breast cancer (HBC) accounts for as much as 10% of the total BC burden. ...Confounding factors include its phenotyp …
The molecular genetics of hereditary and sporadic ovarian cancer: implications for the future.
Al Bakir M, Gabra H. Al Bakir M, et al. Br Med Bull. 2014 Dec;112(1):57-69. doi: 10.1093/bmb/ldu034. Br Med Bull. 2014. PMID: 25473022 Review.
INTRODUCTION: Epithelial ovarian cancer (EOC) is a heterogeneous condition with poor survival outcomes. ...GROWING POINTS: Our understanding of the genetics and frequencies of mutations in ovarian cancer is expanding. The proportion of heritable EOC is …
INTRODUCTION: Epithelial ovarian cancer (EOC) is a heterogeneous condition with poor survival outcomes. ...GROWING POINTS: Our …
Psychological adjustment among male partners in response to women's breast/ovarian cancer risk: a theoretical review of the literature.
Sherman KA, Kasparian NA, Mireskandari S. Sherman KA, et al. Psychooncology. 2010 Jan;19(1):1-11. doi: 10.1002/pon.1582. Psychooncology. 2010. PMID: 19472298 Review.
OBJECTIVE: For women at high risk of developing hereditary breast and/or ovarian cancer the process of undergoing genetic testing is anxiety provoking and stressful, entailing difficult and complex decisions. ...Associations were identified between partner di …
OBJECTIVE: For women at high risk of developing hereditary breast and/or ovarian cancer the process of undergoing genet …
24 results